Get Permission Devi, Manju J, Rajpurohit, Sophia, and Sorokhaibam: Adjuvant therapy for oral submucous fibrosis


Introduction

Oral submucous fibrosis (OSMF) is a chronic precancerous condition which is characterized by juxta-epithelial inflammatory reaction and leads to progressive fibrosis of the submucosal tissues of oral cavity.1 OSMF etiopathogenesis has not been fully understood so far, but areca nut has been reported as main etiological factor. Arecoline and Tanin found in areca nut result in an increased synthesis of collagen and decreased breakdown.2 Chilies, tobacco, lime, dietary deficiency, abnormal iron metabolism, collagen disorders, bacterial infection, immunological disorders, genetic susceptibility and change in salivary composition are also found as other etiological causes.

Symptoms of OSMF differ with progression of disease. Initial signs are ulcerations of the mucosa, and feeling of burning sensation, Stiffness and blanching of oral mucosa occurs as the disease progress. The most distinctive characteristic of OSMF is palpable fibrous bands in oral mucosa3, 4 results in marked stiffness and difficulty to open mouth.5, 6 Other characteristics of the disease include dryness of oral cavity, recurrent ulcer and pigmentation of the oral mucosa, burning sensation, reduced opening of the mouth and protrusion of the tongue. Histopathological review reveals subepithelial fibrosis and chronic inflammation which is followed by hyalinisation and vascular loss, parakeratosis squamous hyperplasia.7, 8

The various treatment protocols which have been attempted to improve the signs and symptoms of OSMF include intralesional injections of corticosteroids, placental extracts and hyaluronidase alone or in combination, laser treatment, surgical, IFN-γ, peripheral vasodilators administration, minerals, sugars, lignin, immune milk, turmeric, lycopene and micronutrient supplements. Various physiotherapeutic modalities have also shown favourable results.9 Natural ayurvedic treatment along with lifestyle change can help to reduce the symptoms of OSMF and thus provide relief to the patient without having to cause side effects.10 This article provides a review of various adjuvant treatment modalities of OSMF.

Adjuvant Therapies

Curcumin

Curcumin is a plant-isolated polyphenol (Curcuma longa) L.(Zingiberaceae) compound found in Southern Asia.11 The exact mechanism of action and determination of bioactive materials have been examined for the medicinal properties of turmeric which is curcumin source.12 It has three properties such as lipid peroxidation inhibition, cellular proliferation screening and inhibition of collagen synthesis.13 Many studies show effects curcumin in increased mouth opening of patient with OSMF. 14 Studies shows improvement in mouth opening and burning sensation.15 Curcumin's antioxidant activity was reported in 1975.16 It acts as an oxygen-free radical scavenger. Curcumin has a powerful inhibitory effect in human keratinocytes and fibroblasts against H2O2-induced damage.17

Aloe Vera

Aloe vera works as a wound-healing hormone and serols that is highly anti-inflammatory. Sudarshan et al reported improvement of burning sensation and opening of the mouth compared with antioxidant treatment.18 Aloe vera contains 75 potentially active constituents which includes vitamins, enzymes, minerals, sugars, lignin, saponins, salicylic acids and amino acids. Vitamins are vitamin A (beta-carotene), C and E which are antioxidants and help to neutralize free radicals. Bradykinase helps decrease inflammation when applied topically to the skin or mucosa. The gel of aloe vera leaves contained polysaccharides which has wound healing, anti-inflammatory, anticancer, immunomodulatory and gastro-protective properties. Properties of aloe vera suggest the possibility of its use in the management of OSMF.19

Tulsi

Tulsi increases immunity and enhances metabolism. It is an extract which has been found inhibiting enzymes to reduce inflammation. It is also decreasing depression and exhibits antioxidant properties.20, 21 It has antioxidant, anti-inflammatory, chemo-preventive, anticarcinogenic and immunomodulatory etc.10, 22 According to Adit Srivastava et al., the synergistic activity of tulsi has resulted in greater effectiveness and highly effective anti-OSMF therapy. During the first month of testing, it triggered an early, prolonged and substantial decrease during burning sensation, both clinically and statistically. Mouth opening has also changed significantly. In extreme cases, the findings were better representing its greater efficacy.23

Sesame oil

Sesame plant (Sesamumindicum/tila) is Pedaliaceae family which was considered a gift of nature to mankind due to its nutritious properties and other beneficial health effects. The seeds are known as "gingelly" or "til". It is a good source of vitamin E with high concentration of polyunsaturated fatty acids and contains antioxidants namely sesamol, sesaminand sesamolin which help in treatment of OSMF.2

Spirulina

It is microalgae, found in native of African and American everyday diets. It contains phenolic acid, tocopherols and beta-carotene with antioxidant properties. Spirulina has been used with positive results in treating many oral mucosal lesions.24 According to Shetty P et al spirulina shows the effective result in treating OSMF pateints.25 Use of spirulina in the successful management of OSMF is attributed to its antioxidant, anti- inflammatory and immuno-modulating properties.26 The blue green algae, spirulina is rich in carotenoids and other micronutrients possessing chemo preventive potential. It has been used to test the clinical activity in reversing the oral precancerous lesions like leukoplakia.27

Lycopene

Lycopene is bright red carotene with carotenoid pigment found in fruits and vegetables including tomatoes, apricots, papaya, watermelon, carrots and other fruits of yellow colour. Through maintaining essential cellular biomolecules including lipids, lipoproteins, proteins and DNA, it helps in preventing carcinogenesis and atherogenesis. It is the most effective biological antioxidant agent which is also used in treatment of OSMF.28, 29 Studies has reported statistically significant of lycopene supplement at a daily dose in improving patients with oral submucous fibrosis.30

Conclusion

OSMF is a chronic debilitating illness, of multifactorial etiology and no single traditional therapy has proven conclusive. Adjuvant medicine is expected to be used for longer periods of time, because they have fewer side effects. It is said to be safe and cost is also less hence it can be used along with traditional treatment of OSMF. Even literature supports the successful outcome of the adjuvant therapies in management of oral submucous fibrosis, but there is inadequate evidence for definitive form of treatment. Therefore, appropriate studies need to be reviewed to increase understanding of adjuvant therapy for treatment of OSMF.

Financial Support and Sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.

References

1 

Jens J. Pindborg Satyavati M. Sirsat Oral submucous fibrosisOral Surg Oral Med, Oral Pathol19662267640030-4220Elsevier BV

2 

W.M. Tilakaratne M.F. Klinikowski Takashi Saku T.J. Peters Saman Warnakulasuriya Oral submucous fibrosis: Review on aetiology and pathogenesisOral Oncol200642656181368-8375Elsevier BV

3 

Chandramani B. More Sunanda Das Hetul Patel Chhaya Adalja Vaishnavee Kamatchi Rashmi Venkatesh Proposed clinical classification for oral submucous fibrosisOral Oncol201248320021368-8375Elsevier BV

4 

AR Kerr S Warnakulasuriya AJ Mighell T Dietrich M Nasser J Rimal A systematic review of medical interventions for oral submucous fibrosis and future research opportunitiesOral Diseases20111742571354-523XWiley

5 

S. Warnakulasuriya Newell. W. Johnson I. Van Der Waal Nomenclature and classification of potentially malignant disorders of the oral mucosaJ Oral Pathol Med20073610575800904-2512Wiley

6 

S R Aziz Oral submucous fibrosis: an unusual diseaseJ N JDentAsooc1997681719

7 

J P Canniff W Harvey M Harris Oral submucous fibrosis: its pathogenesis and managementBr Dent J198616012429340007-0610, 1476-5373Springer Science and Business Media LLC

8 

J J Pindborg F S Mehta D K Daftary Occurrence of Epithelial Atypia in 51 Indian Villagers with Oral Submucous FibrosisBr J Cancer197024225370007-0920, 1532-1827Springer Science and Business Media LLC

9 

T J Sambandan Medical Treatment Modalities of Oral Sub Mucous FibrosisNatl J Integr Res Med2011314751

10 

A Srivastava R Agarwal O P Singh Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational studyJ Ayurveda Integr Med201561459

11 

Santosh K. Sandur Haruyo Ichikawa Manoj K. Pandey Ajaikumar B. Kunnumakkara Bokyung Sung Gautam Sethi Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)Free Radic Biol Med200743568800891-5849Elsevier BV

12 

Prem Prakash Ankita Misra William R. Surin Manish Jain Rabi S. Bhatta Raghvendra Pal Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosisThromb Res20111272111180049-3848Elsevier BV

13 

P Suryanarayana K Krishnaswamy G B Reddy Effect of curcumin on galactose-induced cataractogenesis in ratsMol Vis2003922330

14 

Ramadasan Kuttan P.C. Sudheeran C.D. Josph Turmeric and Curcumin as Topical Agents in Cancer TherapyTumori J19877312990300-8916, 2038-2529SAGE Publications

15 

N Agarwal Evaluation of efficacy of turmeric in management of oral [21] submucous fibrosisJ Indian Acad Oral Med Radiol20142632603

16 

O P Sharma Antioxidant activity of curcumin and related compoundsBiochem Pharmacol19762518112

17 

A.J. Ruby G. Kuttan K. Dinesh Babu K.N. Rajasekharan R. Kuttan Anti-tumour and antioxidant activity of natural curcuminoidsCancer Lett199594179830304-3835Elsevier BV

18 

Ramachandran Sudarshan Rajeshwari G. Annigeri G. Sree Vijayabala Aloe vera in the treatment for oral submucous fibrosis - a preliminary studyJ Oral Pathol Med 20124110755610904-2512Wiley

19 

Nidhi Dwivedi Akhil Agarwal Aloe vera: Magic or mythSRM J Res Dent Sci2013431190976-433XMedknow

20 

P Prakash N Gupta Therapeutic uses of Ocimum sanctum linn (Tulsi) with a note on eugenol and its pharmacological actions: A short reviewIndian J Physiol Pharmacol20054912531

21 

M.A. Kelm M.G. Nair G.M. Strasburg D.L. DeWitt Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.Phytomed2000717130944-7113Elsevier BV

22 

P Bhattacharyya A Bishayee Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancerAnticancer Drugs201324765966

23 

Rahul Agarwal T P Chaturvedi Akhilesh Chandra O P Singh Adit Srivastava Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational studyJ Ayurveda Integr Med201564590975-9476Elsevier BV

24 

M.S. Miranda R.G. Cintra S.B.M. Barros J. Mancini-Filho Antioxidant activity of the microalga Spirulina maximaBraz J Med Biol Res1998318107590100-879XFapUNIFESP (SciELO)

25 

Prathima Shetty Prashanth Shenai Laxmikanth Chatra PrasannaKumar Rao Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosisIndian J Dent Res20132433470970-9290Medknow

26 

Revant H. Chole Shailesh M. Gondivkar Amol R. Gadbail Swati Balsaraf Sudesh Chaudhary Snehal V. Dhore Review of drug treatment of oral submucous fibrosisOral Oncol201248539381368-8375Elsevier BV

27 

Babu Mathew Rengaswamy Sankaranarayanan Padmanabhan P. Nair Cherian Varghese Thara Somanathan B. Padmavathy Amma Evaluation of chemoprevention of oral cancer withspirulina fusiformisNutr Cancer19952421972020163-5581, 1532-7914Informa UK Limited

28 

R Lu H Dan R Wu W Meng N Liu Jin X Lycopene: Features and potential significance in the oral cancer and precancerous lesionsJ Oral Pathol Med2011403618

29 

Nisheeth Saawarn Swati Saawarn Nallan CSK Chaitanya M C Shashikanth Vasanti Jirge R Pinakapani Lycopene in the management of oral lichen planus: A placebo-controlled studyIndian J Dent Res2011225639430970-9290Medknow

30 

Abhinav Kumar Anjana Bagewadi Vaishali Keluskar Mohitpal Singh Efficacy of lycopene in the management of oral submucous fibrosisOral Surg Oral Med Oral Pathol Oral Radiol Endod20071032207131079-2104Elsevier BV



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijohd.2020.018


Article Metrics






Article Access statistics

Viewed: 2820

PDF Downloaded: 665